Maximizing fleet efficiency and ROI with telematics integration [update]

  • December 20, 2025
  • 0 Comments

Photos: Daimler Truck North America Even without clean fleet tax credits and cash-on-the-hood incentives, fleet managers are working hard to maximize their ROI on vehicle assets and reduce their total cost of ownership – and they’re increasingly turning to data‑driven telematics solutions to help. Telematics use data gathered from sensors embedded in a vehicle to […]

Giddyup: Polestar picks up $600 million in fresh funding

  • December 20, 2025
  • 0 Comments

Geely-backed performance EV brand Polestar has had some troubling times in recent months, but its future is looking a whole lot better after the company secured a $600 million loan facility to help it keep on keepin’ on. Despite vehicle sales picking up in 2025 on the strengths of the Polestar EV brand’s Swedish sensibilities, […]

The backup battery choice you didn’t know you had: natural gas fuel cell

  • December 20, 2025
  • 0 Comments

Whether it’s to keep the lights on after a natural disaster or just to avoid peak energy rates, more people than ever are adding battery energy storage to their home solar systems — but li-ion batteries aren’t the only option. The new WATT Fuel Cell uses the natural gas connection your home already has to […]

Mammoet expands electric vehicle fleet with massive XCMG hybrid crane

  • December 20, 2025
  • 0 Comments

French heavy lift and logistics specialists Mammoet are living up to their name with the addition of a new, mammoth-sized, 60-ton hybrid crane from the electric equipment experts at XCMG. The 60-ton XCA60 EV crane from Chinese heavy equipment brand XCMG rides on three heavy-duty axles and packs a 48-meter telescopic boom. Add in an […]

Delaware Court reinstates Musk’s $55B pay package, penalizes him $1 instead

  • December 20, 2025
  • 0 Comments

The Delaware Supreme Court made its ruling in the fight over Tesla CEO Elon Musk’s $55 billion pay package from 2018, reversing the Court of Chancery’s decision and reinstating the pay package. But the Court still penalized Musk $1 plus attorney’s fees due to the award’s unfairness. The ruling is the latest and likely last […]

Oneview and Peterson partnership on patient experience

  • December 20, 2025
  • 0 Comments

Oneview Healthcare has agreed a partnership with Peterson Health to deploy its Care Experience Platform across all inpatient rooms in Kerrville, Texas. Announced on 18 December 2025, the rollout includes 22-inch bedside touchscreens on swing arms and 43-inch digital whiteboards integrated with Meditech Expanse EHR (electronic health record). The tools provide real-time clinical information, support […]

inbs, Vlepis team up on wearable monitoring

  • December 20, 2025
  • 0 Comments

Intelligent Bio Solutions has signed a non-exclusive strategic alliance with Vlepis to develop wearable screening tools and speed its move into consumer health monitoring. Announced on 18 December 2025, the alliance pools research and development, distribution and regulatory expertise to support a faster international rollout. Non-invasive means tests that do not puncture the skin. Wearable […]

GlycanAge raises €7.4m for ageing diagnostics

  • December 20, 2025
  • 0 Comments

GlycanAge has raised €7.4m to expand glycan testing and bring ageing diagnostics into mainstream care. Glycans are complex sugars that coat cells and many proteins, helping control immunity and cell signalling. GlycanAge reads these signals, including an “inflammaging” clock based on IgG glycosylation (sugar chains added to antibodies), to estimate biological age and the impact […]

BioNTech completes CureVac acquisition

  • December 20, 2025
  • 0 Comments

BioNTech has closed its acquisition of CureVac, ending the subsequent offering period and setting up a push to expand mRNA design, delivery and manufacturing. The subsequent offering period expired at 12:01am Eastern Time on 18 December 2025, the company said. BioNTech said 195,341,219 CureVac shares, about 86.75 per cent of those issued and outstanding, were […]

VYNE and Yarrow agree merger to advance YB-101

  • December 20, 2025
  • 0 Comments

VYNE and Yarrow agreed a merger to form Yarrow Bioscience and advance YB-101, a TSH receptor antibody for Graves’ and thyroid eye disease. The all-stock deal will see the combined company operate as Yarrow Bioscience and list on Nasdaq under YARW, subject to approvals. Closing is targeted for the second quarter of 2026. Pre-closing financings […]